Filtered By:
Education: Study
Nutrition: Vitamin B9
This page shows you your search results in order of date.
Order by Relevance | Date
Total 114 results found since Jan 2013.
Early Detection of Subclinical Atherosclerosis: Hyperhomocysteinemia as a Promising Marker in Adolescents With Vitamin B Deficiency
Cureus. 2023 Jul 8;15(7):e41571. doi: 10.7759/cureus.41571. eCollection 2023 Jul.ABSTRACTIn recent decades, the increased incidence of cardiovascular disease (CVD) mortality among young adults has raised concerns. Although clinical manifestations of CVD typically occur later in life, the underlying pathological processes emerge early on. This review article summarizes the association between vitamin B deficiency-induced hyperhomocysteinemia and subclinical atherosclerosis in adolescents. Numerous studies have demonstrated that elevated homocysteine levels are an independent risk factor for endothelial dysfunction (ED) and ...
Source: Atherosclerosis - August 9, 2023 Category: Cardiology Authors: Parth S Shirode Anjali D Parekh Vishwa V Patel Janmay Vala Aniket M Jaimalani Nilofar M Vora Vaishnavi Gummalla Jaineel S Patel Nikitha Shriram Source Type: research
LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases —a phase II study
ConclusionsPanitumumab and FOLFIRI as perioperative therapy for resectable CLM result in a radiological objective response rate in 65.7% of patients with a manageable grade 3 diarrhea rate of 14.3%. Median PFS was 13.2 months, and the 24-month OS rate was 73.3%. These data are insufficient to widen the indication of panitumumab from the unresectable setting to the setting of resectable CLM.
Source: Frontiers in Oncology - August 9, 2023 Category: Cancer & Oncology Source Type: research
Effect of folic acid supplementation on the change of plasma < em > S < /em > -adenosylhomocysteine level in Chinese hypertensive patients: a randomized, double-blind, controlled clinical trial
In conclusion, supplementation of 2.4 mg/day folic acid can lead to increased SAH levels, especially in MTHFR C677T genotype CT and TT.PMID:36447492 | PMC:PMC9701592 | DOI:10.3164/jcbn.22-13
Source: Journal of Clinical Biochemistry and Nutrition - November 30, 2022 Category: Nutrition Authors: Ru-Shan Zhang Lei Tang Yan Zhang Xiu-Li Shi Ji Shu Li Wang Xu Zhang Ya-Ping Xu Jian-Fei Zou Rui Wang Hao Chen Gen-Fu Tang Source Type: research
